panaxadiol has been researched along with Obesity in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 2 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, L; Feng, J; Ge, Y; Guan, F; Han, H; Lv, Y; Xu, M; Yang, X; Zhang, M; Zhang, Y; Zhao, J; Zhao, T | 1 |
| Chen, L; Cheng, F; Feng, J; Guan, F; Lv, Y; Xu, M; Yu, Z; Zhang, M | 1 |
2 other study(ies) available for panaxadiol and Obesity
| Article | Year |
|---|---|
(20R)-Panaxadiol as a Natural Active Component with Anti-Obesity Effects on ob/ob Mice via Modulating the Gut Microbiota.
Topics: Animals; Diabetes Mellitus, Type 2; Diet, High-Fat; Gastrointestinal Microbiome; Ginsenosides; Mice; Mice, Inbred C57BL; Obesity; Panax; RNA, Ribosomal, 16S | 2022 |
Effects of (20 R)-Panaxadiol on NAFLD using non‑targeted metabolomics in stool.
Topics: Animals; Antioxidants; Feces; Liver; Metabolomics; Mice; Mice, Inbred C57BL; Non-alcoholic Fatty Liver Disease; Obesity; Superoxide Dismutase; Tumor Necrosis Factor-alpha | 2023 |